Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accent MicrocellNSE:ACCENTMIC +2.32%47 5-Year Yield-on-Cost % is 0.17 as of Aug. 31, 2026, which is 41% below its 10-year median of 0.29. GuruFocus rates NSE:ACCENTMIC with a GF Score™ of 47/100. The stock has 6 warning signs investors should review. Among 509 Drug Manufacturers companies, Accent Microcell ranks worse than 93.91% on this metric.
Accent Microcell's yield on cost for the quarter that ended in Mar. 2026 was 0.17.
The historical rank and industry rank for Accent Microcell's 5-Year Yield-on-Cost % or its related term are showing as below:
NSE:ACCENTMIC'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.17 Med: 0.29 Max: 0.51
Current: 0.17
During the past 6 years, Accent Microcell's highest Yield on Cost was 0.51. The lowest was 0.17. And the median was 0.29.
NSE:ACCENTMIC's 5-Year Yield-on-Cost % is ranked worse than 93.91% of 509
companies
in the Drug Manufacturers industry
Industry Median: 2.37
vs NSE:ACCENTMIC: 0.17
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Accent Microcell 5-Year Yield-on-Cost % Related Terms
NSE:ACCENTMIC vs ZTS: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accent Microcell 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Accent Microcell's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Accent Microcell (NSE:ACCENTMIC) has a 5-Year Yield-on-Cost % of 0.17 as of Aug. 31, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Accent Microcell and its competitors. This is 41% below median its historical median of 0.29. Over the past decade, Accent Microcell's 5-Year Yield-on-Cost % has ranged from 0.17 to 0.51. According to the industry distribution chart, Accent Microcell ranks #478 out of 509 companies in the Drug Manufacturers industry, placing it in the top 93.9%.
Is Accent Microcell's 5-Year Yield-on-Cost % too high?
Accent Microcell's current 5-Year Yield-on-Cost % of 0.17 is 41% below median its 10-year median of 0.29. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 0.51. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.37. Accent Microcell's value of 0.17 is 92.8% below this industry median. Based on the distribution chart, Accent Microcell ranks #478 out of 509 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Accent Microcell has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Accent Microcell's 5-Year Yield-on-Cost % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Accent Microcell ranks #478 out of 509 companies for 5-Year Yield-on-Cost %. This places Accent Microcell in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.37. Accent Microcell's value of 0.17 is 92.8% below this benchmark. Historically, Accent Microcell's own 5-Year Yield-on-Cost % has ranged from 0.17 to 0.51 over the past decade. While the company's 10-year median is 0.29 vs. the industry median of 2.37, Accent Microcell has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.37, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accent Microcell's current 5-Year Yield-on-Cost % of 0.17 is 92.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Accent Microcell and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accent Microcell's current 5-Year Yield-on-Cost % is 0.17, which is 41% below median its own 10-year median of 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accent Microcell stock overvalued right now?
Accent Microcell (NSE:ACCENTMIC) has a current 5-Year Yield-on-Cost % of 0.17. The current 5-Year Yield-on-Cost % is 0.17, which is 41% below median its 10-year median of 0.29 and 92.8% below the Drug Manufacturers industry median of 2.37. Accent Microcell's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Accent Microcell (NSE:ACCENTMIC), the current 5-Year Yield-on-Cost % is 0.17 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
47GF Score
Get the complete analysis for NSE:ACCENTMIC
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACCENTMIC has been successfully added to your 
